Quantum Biopharma Ltd. Files June 2025 6-K Report
Ticker: QNTM · Form: 6-K · Filed: Jun 27, 2025 · CIK: 1771885
| Field | Detail |
|---|---|
| Company | Quantum Biopharma Ltd. (QNTM) |
| Form Type | 6-K |
| Filed Date | Jun 27, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: 6-K, foreign-issuer, pharmaceutical
TL;DR
Quantum Biopharma (formerly FSD Pharma) filed its June 6-K, standard foreign issuer report from Toronto.
AI Summary
Quantum Biopharma Ltd. (formerly FSD Pharma Inc.) filed a Form 6-K on June 27, 2025. The company, incorporated in A6 and headquartered in Toronto, Canada, operates in the Pharmaceutical Preparations sector. This filing is a report of a foreign private issuer for the month of June 2025.
Why It Matters
This filing provides routine updates for Quantum Biopharma Ltd., a Canadian-based pharmaceutical company, to the SEC, ensuring transparency for investors.
Risk Assessment
Risk Level: low — This filing is a routine report of a foreign private issuer and does not contain significant new financial or operational information that would typically increase risk.
Key Numbers
- 001-39152 — SEC File Number (Identifies the company's filing with the SEC)
Key Players & Entities
- Quantum Biopharma Ltd. (company) — Filer
- FSD Pharma Inc. (company) — Former company name
- 20250627 (date) — Filing date
- 001-39152 (other) — SEC File Number
- Toronto, Ontario (location) — Principal executive office location
FAQ
What is the primary purpose of this Form 6-K filing?
The Form 6-K is a Report of Foreign Private Issuer filed pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934, for the month of June 2025.
What was Quantum Biopharma Ltd.'s former name?
Quantum Biopharma Ltd.'s former company name was FSD Pharma Inc., with a date of name change on March 27, 2019.
Where is Quantum Biopharma Ltd. headquartered?
Quantum Biopharma Ltd.'s principal executive office is located at 55 University Ave., Suite 1003, Toronto, Ontario, Canada.
Does Quantum Biopharma Ltd. file an annual report on Form 20-F or 40-F?
Quantum Biopharma Ltd. indicates it files or will file annual reports under cover of Form 20-F.
What is the Standard Industrial Classification (SIC) code for Quantum Biopharma Ltd.?
The Standard Industrial Classification code for Quantum Biopharma Ltd. is 2834, which corresponds to Pharmaceutical Preparations.
Filing Details
This Form 6-K (Form 6-K) was filed with the SEC on June 27, 2025 regarding Quantum Biopharma Ltd. (QNTM).